Review





Similar Products

98
Jena Bioscience dsrna j2 antibody
Large oncosomes (LOs) engage convergent cytosolic DNA‐ and RNA‐sensing pathways in recipient stromal cells. (A) Heatmap of transcripts uniquely upregulated, Log2 fold change of differentially expressed, and incongruent genes between LO‐treated and small extracellular vesicles (sEV)‐treated human bone marrow‐derived mesenchymal stem cells (BM‐MSCs) relative to vehicle (adjusted p < 0.05). (B) Reactome pathway enrichment analysis of the gene set shown in (A). (C) Gene set enrichment analysis (GSEA) of the Kyoto Encyclopedia of Genes and Genomes (KEGG) cytosolic nucleic acid–sensing pathway in LO‐treated versus sEV‐treated human BM‐MSCs. (D) Direct stochastic optical reconstruction super resolution microscopy (dSTORM) imaging of PC3‐derived LOs labeled with a pan‐EV membrane dye (cyan) and anti‐double stranded DNA (dsDNA) antibody (red). LO‐associated DNA was assessed under four conditions: no permeabilization (External DNA), permeabilization only (internal + external DNA), DNase + permeabilization (DNA digested), and sequential DNase digestion followed by permeabilization (internal DNA). DNase treatment for Internal DNA was performed prior to permeabilization to selectively remove exposed (external) DNA while preserving membrane‐protected internal DNA. Scale bars, 1 and 2 µm. (E) Competitive enzyme‐linked immunosorbent assay (ELISA) quantification of 2'3'‐cyclic GMP‐AMP (2′,3′‐cGAMP) in PC3 cell lysates, PC3‐derived sEV, and LO. (F) Secretable alkaline phosphatase (SEAP) reporter activity in Interferon Stimulated Genes (ISG) reporter cells treated with LO in the presence or absence of stimulator of interferon genes (STING) inhibitor. Poly(I:C) and poly(dA:dT) were included as positive controls. (G–I) Reverse transcription quantitative PCR (RT–qPCR) analysis of interferon regulatory factor 3 ( Irf3 ) and 7 ( Irf7 )(G‐H),, and interferon alpha ( Ifna1)interferon (I) expression in mouse bone marrow cells isolated from wild‐type or Sting Gt mice following LO treatment for 24 h. Expression was normalized to beta actin ( Actb) . (J) Fluorescent western blot confirming STING knockout in human primary BM‐MSCs generated using CRISPR–Cas9. (K) RT–qPCR analysis of viperin ( RSAD2) expression in STING‐knockout and scramble‐control human BM‐MSCs following LO treatment for 24 h. Expression was normalized to Actb. (L) Heatmap showing expression of nucleic acid‐sensing pathway genes in human BM‐MSCs treated with LO or sEV relative to vehicle, based on RNA‐seq data. (M) Immunofluorescence imaging of PC3 cells stained with anti‐double stranded RNA <t>(dsRNA)</t> antibody (red) or isotype control and counterstained with DAPI. Representative images and higher‐magnification views are shown. (N) dSTORM super‐resolution imaging of PC3‐derived LO labeled with a pan‐EV membrane dye (cyan) and anti‐dsRNA antibody (magenta). LO‐associated dsRNA was assessed under four conditions: no permeabilization (External dsRNA), permeabilization only (internal + external dsRNA), RNase III + permeabilization (dsRNA digested), and sequential RNase III digestion followed by permeabilization (internal dsRNA). RNase III treatment for Internal dsRNA was performed prior to permeabilization to selectively remove exposed (external) dsRNA while preserving membrane‐protected internal dsRNA. Scale bars, 1 and 2 µm. (O) Flow cytometry analysis of PC3‐derived LO (> 1 µm) stained with anti‐dsRNA antibody or isotype control. (P–R) RT–qPCR analysis of Ccl5 (P), Irf3 (Q), and Irf7 (R) expression in bone marrow cells isolated from B6;129SF2/J and B6;129‐Mavs tm1Zjc /J (Mavs‐deficient) mice and treated in vitro with PC3‐derived LO. (S) RT–qPCR analysis of RSAD2 expression in human BM‐MSCs treated with LO pre‐incubated with DNase I or RNases. (T) Comparative analysis of gene expression changes in recipient human BM‐MSCs and corresponding EV preparations. Data are shown as LO/sEV ratios. Green bars indicate expression changes in recipient cells, whereas red bars indicate expression levels in EVs. Left, genes altered only in recipient cells and absent or negligible in EV cargo; right, genes showing opposite‐direction changes in recipient cells versus EVs, where response to sEV < response to LO in recipient cells but expression in sEV > expression in LO in EVs. For all in vitro experiments, data represent at least three independent experiments with at least three biological and three technical replicates. Statistical analyses are described in Section .
Dsrna J2 Antibody, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monoclonal+antibody/Anti-dsRNA+monoclonal+antibody+J2/pmc13696780-362-23-26
Average 98 stars, based on 1 article reviews
dsrna j2 antibody - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

96
Bio-Rad rat anti mouse monoclonal f4 80
Large oncosomes (LOs) engage convergent cytosolic DNA‐ and RNA‐sensing pathways in recipient stromal cells. (A) Heatmap of transcripts uniquely upregulated, Log2 fold change of differentially expressed, and incongruent genes between LO‐treated and small extracellular vesicles (sEV)‐treated human bone marrow‐derived mesenchymal stem cells (BM‐MSCs) relative to vehicle (adjusted p < 0.05). (B) Reactome pathway enrichment analysis of the gene set shown in (A). (C) Gene set enrichment analysis (GSEA) of the Kyoto Encyclopedia of Genes and Genomes (KEGG) cytosolic nucleic acid–sensing pathway in LO‐treated versus sEV‐treated human BM‐MSCs. (D) Direct stochastic optical reconstruction super resolution microscopy (dSTORM) imaging of PC3‐derived LOs labeled with a pan‐EV membrane dye (cyan) and anti‐double stranded DNA (dsDNA) antibody (red). LO‐associated DNA was assessed under four conditions: no permeabilization (External DNA), permeabilization only (internal + external DNA), DNase + permeabilization (DNA digested), and sequential DNase digestion followed by permeabilization (internal DNA). DNase treatment for Internal DNA was performed prior to permeabilization to selectively remove exposed (external) DNA while preserving membrane‐protected internal DNA. Scale bars, 1 and 2 µm. (E) Competitive enzyme‐linked immunosorbent assay (ELISA) quantification of 2'3'‐cyclic GMP‐AMP (2′,3′‐cGAMP) in PC3 cell lysates, PC3‐derived sEV, and LO. (F) Secretable alkaline phosphatase (SEAP) reporter activity in Interferon Stimulated Genes (ISG) reporter cells treated with LO in the presence or absence of stimulator of interferon genes (STING) inhibitor. Poly(I:C) and poly(dA:dT) were included as positive controls. (G–I) Reverse transcription quantitative PCR (RT–qPCR) analysis of interferon regulatory factor 3 ( Irf3 ) and 7 ( Irf7 )(G‐H),, and interferon alpha ( Ifna1)interferon (I) expression in mouse bone marrow cells isolated from wild‐type or Sting Gt mice following LO treatment for 24 h. Expression was normalized to beta actin ( Actb) . (J) Fluorescent western blot confirming STING knockout in human primary BM‐MSCs generated using CRISPR–Cas9. (K) RT–qPCR analysis of viperin ( RSAD2) expression in STING‐knockout and scramble‐control human BM‐MSCs following LO treatment for 24 h. Expression was normalized to Actb. (L) Heatmap showing expression of nucleic acid‐sensing pathway genes in human BM‐MSCs treated with LO or sEV relative to vehicle, based on RNA‐seq data. (M) Immunofluorescence imaging of PC3 cells stained with anti‐double stranded RNA <t>(dsRNA)</t> antibody (red) or isotype control and counterstained with DAPI. Representative images and higher‐magnification views are shown. (N) dSTORM super‐resolution imaging of PC3‐derived LO labeled with a pan‐EV membrane dye (cyan) and anti‐dsRNA antibody (magenta). LO‐associated dsRNA was assessed under four conditions: no permeabilization (External dsRNA), permeabilization only (internal + external dsRNA), RNase III + permeabilization (dsRNA digested), and sequential RNase III digestion followed by permeabilization (internal dsRNA). RNase III treatment for Internal dsRNA was performed prior to permeabilization to selectively remove exposed (external) dsRNA while preserving membrane‐protected internal dsRNA. Scale bars, 1 and 2 µm. (O) Flow cytometry analysis of PC3‐derived LO (> 1 µm) stained with anti‐dsRNA antibody or isotype control. (P–R) RT–qPCR analysis of Ccl5 (P), Irf3 (Q), and Irf7 (R) expression in bone marrow cells isolated from B6;129SF2/J and B6;129‐Mavs tm1Zjc /J (Mavs‐deficient) mice and treated in vitro with PC3‐derived LO. (S) RT–qPCR analysis of RSAD2 expression in human BM‐MSCs treated with LO pre‐incubated with DNase I or RNases. (T) Comparative analysis of gene expression changes in recipient human BM‐MSCs and corresponding EV preparations. Data are shown as LO/sEV ratios. Green bars indicate expression changes in recipient cells, whereas red bars indicate expression levels in EVs. Left, genes altered only in recipient cells and absent or negligible in EV cargo; right, genes showing opposite‐direction changes in recipient cells versus EVs, where response to sEV < response to LO in recipient cells but expression in sEV > expression in LO in EVs. For all in vitro experiments, data represent at least three independent experiments with at least three biological and three technical replicates. Statistical analyses are described in Section .
Rat Anti Mouse Monoclonal F4 80, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monoclonal+antibody/Rat+anti+Mouse+F4%2F80/10__22203_slash_ecm__v033a11-129-8-16
Average 96 stars, based on 1 article reviews
rat anti mouse monoclonal f4 80 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Hypoxyprobe inc pimonidazole (monoclonal igg1 antibody, mab1
Large oncosomes (LOs) engage convergent cytosolic DNA‐ and RNA‐sensing pathways in recipient stromal cells. (A) Heatmap of transcripts uniquely upregulated, Log2 fold change of differentially expressed, and incongruent genes between LO‐treated and small extracellular vesicles (sEV)‐treated human bone marrow‐derived mesenchymal stem cells (BM‐MSCs) relative to vehicle (adjusted p < 0.05). (B) Reactome pathway enrichment analysis of the gene set shown in (A). (C) Gene set enrichment analysis (GSEA) of the Kyoto Encyclopedia of Genes and Genomes (KEGG) cytosolic nucleic acid–sensing pathway in LO‐treated versus sEV‐treated human BM‐MSCs. (D) Direct stochastic optical reconstruction super resolution microscopy (dSTORM) imaging of PC3‐derived LOs labeled with a pan‐EV membrane dye (cyan) and anti‐double stranded DNA (dsDNA) antibody (red). LO‐associated DNA was assessed under four conditions: no permeabilization (External DNA), permeabilization only (internal + external DNA), DNase + permeabilization (DNA digested), and sequential DNase digestion followed by permeabilization (internal DNA). DNase treatment for Internal DNA was performed prior to permeabilization to selectively remove exposed (external) DNA while preserving membrane‐protected internal DNA. Scale bars, 1 and 2 µm. (E) Competitive enzyme‐linked immunosorbent assay (ELISA) quantification of 2'3'‐cyclic GMP‐AMP (2′,3′‐cGAMP) in PC3 cell lysates, PC3‐derived sEV, and LO. (F) Secretable alkaline phosphatase (SEAP) reporter activity in Interferon Stimulated Genes (ISG) reporter cells treated with LO in the presence or absence of stimulator of interferon genes (STING) inhibitor. Poly(I:C) and poly(dA:dT) were included as positive controls. (G–I) Reverse transcription quantitative PCR (RT–qPCR) analysis of interferon regulatory factor 3 ( Irf3 ) and 7 ( Irf7 )(G‐H),, and interferon alpha ( Ifna1)interferon (I) expression in mouse bone marrow cells isolated from wild‐type or Sting Gt mice following LO treatment for 24 h. Expression was normalized to beta actin ( Actb) . (J) Fluorescent western blot confirming STING knockout in human primary BM‐MSCs generated using CRISPR–Cas9. (K) RT–qPCR analysis of viperin ( RSAD2) expression in STING‐knockout and scramble‐control human BM‐MSCs following LO treatment for 24 h. Expression was normalized to Actb. (L) Heatmap showing expression of nucleic acid‐sensing pathway genes in human BM‐MSCs treated with LO or sEV relative to vehicle, based on RNA‐seq data. (M) Immunofluorescence imaging of PC3 cells stained with anti‐double stranded RNA <t>(dsRNA)</t> antibody (red) or isotype control and counterstained with DAPI. Representative images and higher‐magnification views are shown. (N) dSTORM super‐resolution imaging of PC3‐derived LO labeled with a pan‐EV membrane dye (cyan) and anti‐dsRNA antibody (magenta). LO‐associated dsRNA was assessed under four conditions: no permeabilization (External dsRNA), permeabilization only (internal + external dsRNA), RNase III + permeabilization (dsRNA digested), and sequential RNase III digestion followed by permeabilization (internal dsRNA). RNase III treatment for Internal dsRNA was performed prior to permeabilization to selectively remove exposed (external) dsRNA while preserving membrane‐protected internal dsRNA. Scale bars, 1 and 2 µm. (O) Flow cytometry analysis of PC3‐derived LO (> 1 µm) stained with anti‐dsRNA antibody or isotype control. (P–R) RT–qPCR analysis of Ccl5 (P), Irf3 (Q), and Irf7 (R) expression in bone marrow cells isolated from B6;129SF2/J and B6;129‐Mavs tm1Zjc /J (Mavs‐deficient) mice and treated in vitro with PC3‐derived LO. (S) RT–qPCR analysis of RSAD2 expression in human BM‐MSCs treated with LO pre‐incubated with DNase I or RNases. (T) Comparative analysis of gene expression changes in recipient human BM‐MSCs and corresponding EV preparations. Data are shown as LO/sEV ratios. Green bars indicate expression changes in recipient cells, whereas red bars indicate expression levels in EVs. Left, genes altered only in recipient cells and absent or negligible in EV cargo; right, genes showing opposite‐direction changes in recipient cells versus EVs, where response to sEV < response to LO in recipient cells but expression in sEV > expression in LO in EVs. For all in vitro experiments, data represent at least three independent experiments with at least three biological and three technical replicates. Statistical analyses are described in Section .
Pimonidazole (Monoclonal Igg1 Antibody, Mab1, supplied by Hypoxyprobe inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monoclonal+antibody/anti+pimonidazole/nct06085781-10-10-16
Average 90 stars, based on 1 article reviews
pimonidazole (monoclonal igg1 antibody, mab1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc akt substrate 160
Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and <t>AS160</t> phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 <t>S318,</t> and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.
Akt Substrate 160, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monoclonal+antibody/Phospho-AS160+(Ser318)+Rabbit+mAb/pmc12816905-99-63-69
Average 93 stars, based on 1 article reviews
akt substrate 160 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc as160 t642
Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and <t>AS160</t> phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 <t>T642</t> in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.
As160 T642, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monoclonal+antibody/Phospho-AS160+(Thr642)+Rabbit+mAb/pmc12816905-99-72-75
Average 95 stars, based on 1 article reviews
as160 t642 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc phospho as160
Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and <t>AS160</t> phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 <t>T642</t> in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.
Phospho As160, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monoclonal+antibody/Phospho-AS160+(Ser588)+Rabbit+mAb/pmc12811471-130-38-40
Average 94 stars, based on 1 article reviews
phospho as160 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

98
Proteintech 60004 1 ig
Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and <t>AS160</t> phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 <t>T642</t> in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.
60004 1 Ig, supplied by Proteintech, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monoclonal+antibody/GAPDH+Monoclonal+antibody/pm42927029-212-153-154
Average 98 stars, based on 1 article reviews
60004 1 ig - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

93
ABclonal Biotechnology h2a
Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and <t>AS160</t> phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 <t>T642</t> in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.
H2a, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monoclonal+antibody/Histone+H2A+Rabbit+mAb/pmc13695081-53-9-55
Average 93 stars, based on 1 article reviews
h2a - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
ABclonal Biotechnology glucose regulated protein 78
Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and <t>AS160</t> phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 <t>T642</t> in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.
Glucose Regulated Protein 78, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monoclonal+antibody/BiP%2FGRP78+Rabbit+mAb/pmc13695081-53-34-55
Average 93 stars, based on 1 article reviews
glucose regulated protein 78 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

98
Proteintech glyceraldehyde 3 phosphate dehydrogenase
( A ) Pie chart showing the proportion and number of methylated1 and escapee1 5-kb bins from TE to the first-trimester CTB. ( B ) Pie chart showing the proportion and number of methylated2 and escapee2 5-kb bins from the first- to third-trimester CTB. ( C ) Box plots showing the DNA methylation, H3K9me3, H3K9ac, and expression levels of genes and repeats undergoing methylation (genes, 25,044; repeats, 3,799,552) or escapee (genes, 10,225; repeats, 232,372) in the first-trimester CTB from TE to the first trimester. Significance between the groups was evaluated by Student’s t test. ( D ) GO enrichment analysis for methylated1 and escapee1 genes from TE to the first-trimester CTB. ( E ) qRT-PCR analysis of representative methylated1 or escapee1 genes in human embryonic stem cell (hESC), hTSC, and the <t>first-trimester</t> <t>CTB.</t> <t>Glyceraldehyde-3-phosphate</t> dehydrogenase ( GAPDH ) is set as an endogenous control. Data are presented as means ± SD (three biological replicates). ( F ) Box plots showing the DNA methylation, H3K9me3, H3K9ac, and expression levels of genes and repeats undergoing methylation (genes, 22,098; repeats, 2,847,005) or escapee (genes, 15,384; repeats, 1,217,495) in the third-trimester CTB from the first to third trimesters. Significance between the groups was evaluated by Student’s t test.
Glyceraldehyde 3 Phosphate Dehydrogenase, supplied by Proteintech, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monoclonal+antibody/GAPDH+Monoclonal+antibody/pmc13693670-257-31-35
Average 98 stars, based on 1 article reviews
glyceraldehyde 3 phosphate dehydrogenase - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

Image Search Results


Large oncosomes (LOs) engage convergent cytosolic DNA‐ and RNA‐sensing pathways in recipient stromal cells. (A) Heatmap of transcripts uniquely upregulated, Log2 fold change of differentially expressed, and incongruent genes between LO‐treated and small extracellular vesicles (sEV)‐treated human bone marrow‐derived mesenchymal stem cells (BM‐MSCs) relative to vehicle (adjusted p < 0.05). (B) Reactome pathway enrichment analysis of the gene set shown in (A). (C) Gene set enrichment analysis (GSEA) of the Kyoto Encyclopedia of Genes and Genomes (KEGG) cytosolic nucleic acid–sensing pathway in LO‐treated versus sEV‐treated human BM‐MSCs. (D) Direct stochastic optical reconstruction super resolution microscopy (dSTORM) imaging of PC3‐derived LOs labeled with a pan‐EV membrane dye (cyan) and anti‐double stranded DNA (dsDNA) antibody (red). LO‐associated DNA was assessed under four conditions: no permeabilization (External DNA), permeabilization only (internal + external DNA), DNase + permeabilization (DNA digested), and sequential DNase digestion followed by permeabilization (internal DNA). DNase treatment for Internal DNA was performed prior to permeabilization to selectively remove exposed (external) DNA while preserving membrane‐protected internal DNA. Scale bars, 1 and 2 µm. (E) Competitive enzyme‐linked immunosorbent assay (ELISA) quantification of 2'3'‐cyclic GMP‐AMP (2′,3′‐cGAMP) in PC3 cell lysates, PC3‐derived sEV, and LO. (F) Secretable alkaline phosphatase (SEAP) reporter activity in Interferon Stimulated Genes (ISG) reporter cells treated with LO in the presence or absence of stimulator of interferon genes (STING) inhibitor. Poly(I:C) and poly(dA:dT) were included as positive controls. (G–I) Reverse transcription quantitative PCR (RT–qPCR) analysis of interferon regulatory factor 3 ( Irf3 ) and 7 ( Irf7 )(G‐H),, and interferon alpha ( Ifna1)interferon (I) expression in mouse bone marrow cells isolated from wild‐type or Sting Gt mice following LO treatment for 24 h. Expression was normalized to beta actin ( Actb) . (J) Fluorescent western blot confirming STING knockout in human primary BM‐MSCs generated using CRISPR–Cas9. (K) RT–qPCR analysis of viperin ( RSAD2) expression in STING‐knockout and scramble‐control human BM‐MSCs following LO treatment for 24 h. Expression was normalized to Actb. (L) Heatmap showing expression of nucleic acid‐sensing pathway genes in human BM‐MSCs treated with LO or sEV relative to vehicle, based on RNA‐seq data. (M) Immunofluorescence imaging of PC3 cells stained with anti‐double stranded RNA (dsRNA) antibody (red) or isotype control and counterstained with DAPI. Representative images and higher‐magnification views are shown. (N) dSTORM super‐resolution imaging of PC3‐derived LO labeled with a pan‐EV membrane dye (cyan) and anti‐dsRNA antibody (magenta). LO‐associated dsRNA was assessed under four conditions: no permeabilization (External dsRNA), permeabilization only (internal + external dsRNA), RNase III + permeabilization (dsRNA digested), and sequential RNase III digestion followed by permeabilization (internal dsRNA). RNase III treatment for Internal dsRNA was performed prior to permeabilization to selectively remove exposed (external) dsRNA while preserving membrane‐protected internal dsRNA. Scale bars, 1 and 2 µm. (O) Flow cytometry analysis of PC3‐derived LO (> 1 µm) stained with anti‐dsRNA antibody or isotype control. (P–R) RT–qPCR analysis of Ccl5 (P), Irf3 (Q), and Irf7 (R) expression in bone marrow cells isolated from B6;129SF2/J and B6;129‐Mavs tm1Zjc /J (Mavs‐deficient) mice and treated in vitro with PC3‐derived LO. (S) RT–qPCR analysis of RSAD2 expression in human BM‐MSCs treated with LO pre‐incubated with DNase I or RNases. (T) Comparative analysis of gene expression changes in recipient human BM‐MSCs and corresponding EV preparations. Data are shown as LO/sEV ratios. Green bars indicate expression changes in recipient cells, whereas red bars indicate expression levels in EVs. Left, genes altered only in recipient cells and absent or negligible in EV cargo; right, genes showing opposite‐direction changes in recipient cells versus EVs, where response to sEV < response to LO in recipient cells but expression in sEV > expression in LO in EVs. For all in vitro experiments, data represent at least three independent experiments with at least three biological and three technical replicates. Statistical analyses are described in Section .

Journal: Advanced Science

Article Title: Large Oncosomes Induce Pro‐Metastatic Stromal‐Myeloid Reprogramming

doi: 10.1002/advs.78406

Figure Lengend Snippet: Large oncosomes (LOs) engage convergent cytosolic DNA‐ and RNA‐sensing pathways in recipient stromal cells. (A) Heatmap of transcripts uniquely upregulated, Log2 fold change of differentially expressed, and incongruent genes between LO‐treated and small extracellular vesicles (sEV)‐treated human bone marrow‐derived mesenchymal stem cells (BM‐MSCs) relative to vehicle (adjusted p < 0.05). (B) Reactome pathway enrichment analysis of the gene set shown in (A). (C) Gene set enrichment analysis (GSEA) of the Kyoto Encyclopedia of Genes and Genomes (KEGG) cytosolic nucleic acid–sensing pathway in LO‐treated versus sEV‐treated human BM‐MSCs. (D) Direct stochastic optical reconstruction super resolution microscopy (dSTORM) imaging of PC3‐derived LOs labeled with a pan‐EV membrane dye (cyan) and anti‐double stranded DNA (dsDNA) antibody (red). LO‐associated DNA was assessed under four conditions: no permeabilization (External DNA), permeabilization only (internal + external DNA), DNase + permeabilization (DNA digested), and sequential DNase digestion followed by permeabilization (internal DNA). DNase treatment for Internal DNA was performed prior to permeabilization to selectively remove exposed (external) DNA while preserving membrane‐protected internal DNA. Scale bars, 1 and 2 µm. (E) Competitive enzyme‐linked immunosorbent assay (ELISA) quantification of 2'3'‐cyclic GMP‐AMP (2′,3′‐cGAMP) in PC3 cell lysates, PC3‐derived sEV, and LO. (F) Secretable alkaline phosphatase (SEAP) reporter activity in Interferon Stimulated Genes (ISG) reporter cells treated with LO in the presence or absence of stimulator of interferon genes (STING) inhibitor. Poly(I:C) and poly(dA:dT) were included as positive controls. (G–I) Reverse transcription quantitative PCR (RT–qPCR) analysis of interferon regulatory factor 3 ( Irf3 ) and 7 ( Irf7 )(G‐H),, and interferon alpha ( Ifna1)interferon (I) expression in mouse bone marrow cells isolated from wild‐type or Sting Gt mice following LO treatment for 24 h. Expression was normalized to beta actin ( Actb) . (J) Fluorescent western blot confirming STING knockout in human primary BM‐MSCs generated using CRISPR–Cas9. (K) RT–qPCR analysis of viperin ( RSAD2) expression in STING‐knockout and scramble‐control human BM‐MSCs following LO treatment for 24 h. Expression was normalized to Actb. (L) Heatmap showing expression of nucleic acid‐sensing pathway genes in human BM‐MSCs treated with LO or sEV relative to vehicle, based on RNA‐seq data. (M) Immunofluorescence imaging of PC3 cells stained with anti‐double stranded RNA (dsRNA) antibody (red) or isotype control and counterstained with DAPI. Representative images and higher‐magnification views are shown. (N) dSTORM super‐resolution imaging of PC3‐derived LO labeled with a pan‐EV membrane dye (cyan) and anti‐dsRNA antibody (magenta). LO‐associated dsRNA was assessed under four conditions: no permeabilization (External dsRNA), permeabilization only (internal + external dsRNA), RNase III + permeabilization (dsRNA digested), and sequential RNase III digestion followed by permeabilization (internal dsRNA). RNase III treatment for Internal dsRNA was performed prior to permeabilization to selectively remove exposed (external) dsRNA while preserving membrane‐protected internal dsRNA. Scale bars, 1 and 2 µm. (O) Flow cytometry analysis of PC3‐derived LO (> 1 µm) stained with anti‐dsRNA antibody or isotype control. (P–R) RT–qPCR analysis of Ccl5 (P), Irf3 (Q), and Irf7 (R) expression in bone marrow cells isolated from B6;129SF2/J and B6;129‐Mavs tm1Zjc /J (Mavs‐deficient) mice and treated in vitro with PC3‐derived LO. (S) RT–qPCR analysis of RSAD2 expression in human BM‐MSCs treated with LO pre‐incubated with DNase I or RNases. (T) Comparative analysis of gene expression changes in recipient human BM‐MSCs and corresponding EV preparations. Data are shown as LO/sEV ratios. Green bars indicate expression changes in recipient cells, whereas red bars indicate expression levels in EVs. Left, genes altered only in recipient cells and absent or negligible in EV cargo; right, genes showing opposite‐direction changes in recipient cells versus EVs, where response to sEV < response to LO in recipient cells but expression in sEV > expression in LO in EVs. For all in vitro experiments, data represent at least three independent experiments with at least three biological and three technical replicates. Statistical analyses are described in Section .

Article Snippet: Cells seeded in round cover class, after 24 h cells were fixed and permeabilized using BD Cytofix/Cytoperm Fixation/Permeabilization Solution Kit, and stained with dsRNA J2 antibody (Jena Bioscience, rabbit‐raised, 1:100 for cell imaging), rhodamine‐phalloidin (Cytoskeleton Inc., #PHDR1, 100 nM), WGA‐AF488 or WGA‐AF555 (Invitrogen, # W11261 /# W32464 , 1 μg/mL), and DAPI (Invitrogen, #62248, 1 μg/mL) across different experiments.

Techniques: Derivative Assay, Analysis, Gene Set Enrichment Analysis, Super-Resolution Microscopy, Stochastic Optical Reconstruction Microscopy, Imaging, Labeling, Membrane, Preserving, Competitive ELISA, Enzyme-linked Immunosorbent Assay, Activity Assay, Reverse Transcription, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Expressing, Isolation, Western Blot, Knock-Out, Generated, CRISPR, Control, RNA Sequencing, Immunofluorescence, Staining, Super Resolution, Flow Cytometry, In Vitro, Incubation, Gene Expression

Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.

Journal: Journal of Sport and Health Science

Article Title: Weightlifting outperforms voluntary wheel running for improving adiposity and insulin sensitivity in obese mice

doi: 10.1016/j.jshs.2025.101100

Figure Lengend Snippet: Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.

Article Snippet: Primary antibodies used for analysis were from Cell Signaling Technologies (Danvers, MA, USA) and diluted 1:1000 unless otherwise stated as follows: protein kinase B (Akt; 1:500; #4691; Cell Signaling Technologies), phospho-Akt (pAkt) S473 (1:500; #9271; Cell Signaling Technologies), Ubiquitin (#3933; Cell Signaling Technologies), microtubule-associated protein light chain 3 (LC3 II/I; #4018; Cell Signaling Technologies), cytochrome c oxidase subunit 4(COX4; #11967; Cell Signaling Technologies), Akt substrate 160 (AS160 S318; #8619; Cell Signaling Technologies), AS160 T642 (#8881; Cell Signaling Technologies), eukaryotic translation initiation factor 4E binding protein (4E-BP1; #9452; Cell Signaling Technologies), and glyceraldehyde 3 phosphate dehydrogenase (GAPDH; #2118; Cell Signaling Technologies).

Techniques: Phospho-proteomics, Injection, Western Blot, Muscles, Ubiquitin Proteomics, Staining, Binding Assay

Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.

Journal: Journal of Sport and Health Science

Article Title: Weightlifting outperforms voluntary wheel running for improving adiposity and insulin sensitivity in obese mice

doi: 10.1016/j.jshs.2025.101100

Figure Lengend Snippet: Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.

Article Snippet: Primary antibodies used for analysis were from Cell Signaling Technologies (Danvers, MA, USA) and diluted 1:1000 unless otherwise stated as follows: protein kinase B (Akt; 1:500; #4691; Cell Signaling Technologies), phospho-Akt (pAkt) S473 (1:500; #9271; Cell Signaling Technologies), Ubiquitin (#3933; Cell Signaling Technologies), microtubule-associated protein light chain 3 (LC3 II/I; #4018; Cell Signaling Technologies), cytochrome c oxidase subunit 4(COX4; #11967; Cell Signaling Technologies), Akt substrate 160 (AS160 S318; #8619; Cell Signaling Technologies), AS160 T642 (#8881; Cell Signaling Technologies), eukaryotic translation initiation factor 4E binding protein (4E-BP1; #9452; Cell Signaling Technologies), and glyceraldehyde 3 phosphate dehydrogenase (GAPDH; #2118; Cell Signaling Technologies).

Techniques: Phospho-proteomics, Injection, Western Blot, Muscles, Ubiquitin Proteomics, Staining, Binding Assay

( A ) Pie chart showing the proportion and number of methylated1 and escapee1 5-kb bins from TE to the first-trimester CTB. ( B ) Pie chart showing the proportion and number of methylated2 and escapee2 5-kb bins from the first- to third-trimester CTB. ( C ) Box plots showing the DNA methylation, H3K9me3, H3K9ac, and expression levels of genes and repeats undergoing methylation (genes, 25,044; repeats, 3,799,552) or escapee (genes, 10,225; repeats, 232,372) in the first-trimester CTB from TE to the first trimester. Significance between the groups was evaluated by Student’s t test. ( D ) GO enrichment analysis for methylated1 and escapee1 genes from TE to the first-trimester CTB. ( E ) qRT-PCR analysis of representative methylated1 or escapee1 genes in human embryonic stem cell (hESC), hTSC, and the first-trimester CTB. Glyceraldehyde-3-phosphate dehydrogenase ( GAPDH ) is set as an endogenous control. Data are presented as means ± SD (three biological replicates). ( F ) Box plots showing the DNA methylation, H3K9me3, H3K9ac, and expression levels of genes and repeats undergoing methylation (genes, 22,098; repeats, 2,847,005) or escapee (genes, 15,384; repeats, 1,217,495) in the third-trimester CTB from the first to third trimesters. Significance between the groups was evaluated by Student’s t test.

Journal: Science Advances

Article Title: Lineage-specific and gestational age–dependent DNA methylation programming orchestrates human placental development

doi: 10.1126/sciadv.aee0560

Figure Lengend Snippet: ( A ) Pie chart showing the proportion and number of methylated1 and escapee1 5-kb bins from TE to the first-trimester CTB. ( B ) Pie chart showing the proportion and number of methylated2 and escapee2 5-kb bins from the first- to third-trimester CTB. ( C ) Box plots showing the DNA methylation, H3K9me3, H3K9ac, and expression levels of genes and repeats undergoing methylation (genes, 25,044; repeats, 3,799,552) or escapee (genes, 10,225; repeats, 232,372) in the first-trimester CTB from TE to the first trimester. Significance between the groups was evaluated by Student’s t test. ( D ) GO enrichment analysis for methylated1 and escapee1 genes from TE to the first-trimester CTB. ( E ) qRT-PCR analysis of representative methylated1 or escapee1 genes in human embryonic stem cell (hESC), hTSC, and the first-trimester CTB. Glyceraldehyde-3-phosphate dehydrogenase ( GAPDH ) is set as an endogenous control. Data are presented as means ± SD (three biological replicates). ( F ) Box plots showing the DNA methylation, H3K9me3, H3K9ac, and expression levels of genes and repeats undergoing methylation (genes, 22,098; repeats, 2,847,005) or escapee (genes, 15,384; repeats, 1,217,495) in the third-trimester CTB from the first to third trimesters. Significance between the groups was evaluated by Student’s t test.

Article Snippet: The membranes were blocked with protein-free rapid blocking buffer and next incubated with EED (85322S, Cell Signaling Technology), EZH2 (39901, Active motif), SUZ12 (3737S, Cell Signaling Technology), H3K9me3 (39161, Active motif), glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 60004-1-Ig, Proteintech), H3K27me3 (C15410195, Diagenode), H3 (4499, Cell Signaling Technology), CDH1 (3195S, Cell Signaling Technology), CDH2 (ab18203, Abcam), EpCAM (MA5-12436, Thermo Fisher Scientific), MMP2 (40994S, Cell Signaling Technology), and DNMT1 (24206-1-AP, Proteintech) overnight at 4°C on a shaker.

Techniques: DNA Methylation Assay, Expressing, Methylation, Analysis, Quantitative RT-PCR, Stem Cell, Control, Significance Assay